These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Amarzguioui M, Peng Q, Wiiger MT, Vasovic V, Babaie E, Holen T, Nesland JM, Prydz H. Clin Cancer Res; 2006 Jul 01; 12(13):4055-61. PubMed ID: 16818705 [Abstract] [Full Text] [Related]
24. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla. Meade BR, Dowdy SF. Discov Med; 2009 Dec 01; 8(43):253-6. PubMed ID: 20040280 [Abstract] [Full Text] [Related]
25. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases. Takahashi Y, Nishikawa M, Kobayashi N, Takakura Y. J Control Release; 2005 Jul 20; 105(3):332-43. PubMed ID: 15936841 [Abstract] [Full Text] [Related]
26. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment. Yonenaga N, Kenjo E, Asai T, Tsuruta A, Shimizu K, Dewa T, Nango M, Oku N. J Control Release; 2012 Jun 10; 160(2):177-81. PubMed ID: 22019557 [Abstract] [Full Text] [Related]
30. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X, Li DC, Zhao H, Li Z, Wang JX, Zhu DM, Zhou J, Cen JN. Oncol Rep; 2012 Mar 10; 27(3):628-36. PubMed ID: 22200682 [Abstract] [Full Text] [Related]
34. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Santel A, Aleku M, Keil O, Endruschat J, Esche V, Durieux B, Löffler K, Fechtner M, Röhl T, Fisch G, Dames S, Arnold W, Giese K, Klippel A, Kaufmann J. Gene Ther; 2006 Sep 10; 13(18):1360-70. PubMed ID: 16625242 [Abstract] [Full Text] [Related]
35. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Pirollo KF, Rait A, Zhou Q, Hwang SH, Dagata JA, Zon G, Hogrefe RI, Palchik G, Chang EH. Cancer Res; 2007 Apr 01; 67(7):2938-43. PubMed ID: 17409398 [Abstract] [Full Text] [Related]
39. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference]. Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL. Ai Zheng; 2004 Jun 01; 23(6):619-25. PubMed ID: 15191658 [Abstract] [Full Text] [Related]